Sign in
4

Changes in Ownership

Nuvectis Pharma, Inc. Filed Acc 0001104659-23-083472

Chairman & CEO bought 335 shares at an average $14.92 ($4,998)

From the SEC's structured data for this filing

Trades in this filing

BENTSUR RON · Chairman & CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-07-20 Purchase : show line 1 in the form +110 $15.06 $1,657 3,231,669 D
2023-07-21 Purchase : show line 2 in the form +225 $14.85 $3,341 3,231,894 D
Open-market purchases · 335 sh · avg $14.92 · $4,998
Loading xslF345X05/tm2321778-2_4seq1.xml…